dyslipidemia
DYSLIPIDEMIA
Dyslipidemia is having an abnormal amount of lipids or fats in the blood.
Lipid profile is obtained from an individual with diabetes mellitus, coronary heart disease, cerebrovascular disease, peripheral arterial disease or other coronary heart disease risk factors or from an individual with family history or clinical evidence of familial hypercholesterolemia.
Plasma lipids are total cholesterol, high-density lipoprotein cholesterol, trigylcerides, and low-density lipoprotein cholesterol.
Evaluation of lipid profile must be performed in parallel with the risk assessment of coronary heart disease.
Drug Information
Atozet
atorvastatin + ezetimibe

Indication: Reduced risk of CV death, nonfatal MI & stroke, hospitalization for unstable angina or need for revascular...

Indication: Reduction of elevated total cholesterol (total-C), LDL-C, ApoB, the total-C: HDL-C ratio & triglycerides &...

Indication: Adjunct to diet & other non-pharmacological treatment for severe hypertriglyceridaemia w/ or w/o low HDL c...

Indication: Primary hypercholesterolaemia: Administered alone or w/ an HMG-CoA reductase inhibitor (statin) indicated as a...

Indication: Adjunct to diet for the treatment of patients w/ elevated total & LDL cholesterol, apolipoprotein B & ...

Indication: Primary hypercholesterolemia: Adjunctive therapy to diet for the reduction of elevated total cholesterol (tota...

Indication: Adjunct to diet for patients w/ elevated total cholesterol, LDL-cholesterol, apolipoprotein B & triglyceri...

Indication: Hyperlipidaemia.

Indication: Patients for whom treatment w/ both amlodipine & atorvastatin is appropriate: Amlodipine component 1st-lin...

Indication: Hypercholesterolaemia & hypertriglyceridaemia alone or combined (types IIa, IIb, III, IV, V dyslipidaemias...

1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
07 Sep 2019
Eating mushrooms has no correlation with biomarkers and risks of cardiovascular disease (CVD) and type 2 diabetes (T2D) in adults, a US study has shown.
03 Sep 2019
Sleep apnoea is highly prevalent but largely undetected in the general population of middle-aged adults, with a symptom-based strategy proving to be useless for specific diagnosis, according to a recent study. Moreover, mild sleep apnoea represents a higher-risk phenotype with manifestly increased metabolic, inflammatory and cardiovascular risk factor burden, with potential public health implications.
Rachel Soon, Yesterday

Adding simvastatin as an adjuvant to standard triple therapy in Helicobacter pylori treatment may help compensate for increasing antimicrobial resistance, according to a new study.

Christina Lau, 03 Sep 2019
The sodium-glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin significantly reduces the risk of death and hospitalization in patients with heart failure (HF) with reduced ejection fraction (rEF) regardless of whether they have type 2 diabetes mellitus (T2DM), the DAPA-HF trial has shown.